Assyro AI

Orange Book product · Generic (ANDA)

CAFFEINE CITRATE

CAFFEINE CITRATE

Generic (ANDA)ANDA 091102TE AARX SAGENT PHARMS
View CAFFEINE CITRATE familyOpen on FDA Orange Book

At a glance

Aug 29, 2012

Approved

Generic (ANDA)

Application

AA

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 29, 2012

    14 yr ago

  2. Today

Pharmaceutical detail

Active ingredient

CAFFEINE CITRATE

Strength

EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

Dosage form

SOLUTION

Route

ORAL

TE code

AA

Application

ANDA 091102

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of CAFFEINE CITRATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo